Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jum.15879 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis.
Arch Dermatol Res
December 2024
Department of Allergy and Clinical Immunology, Mashhad University of Medical Sciences, Mashhad, Iran.
Chronic urticaria is a persistent skin condition characterized by recurrent wheals (hives) and/or angioedema lasting more than six weeks, significantly impacting quality of life and often requiring long-term management. Limited access to costly treatments like omalizumab poses challenges in low-income countries with high healthcare expenses and limited insurance coverage, prompting research into cost-effective dosages for effective management. This study aims to find the most cost-effective dosage for treating chronic urticaria in countries with healthcare affordability challenges.
View Article and Find Full Text PDFIf antibiotics aren't always the answer-what is?
Pediatr Res
October 2024
SAPPHIRE Group, Population Health Sciences, Leicester University, Leicester, UK.
Clinician Stakeholder Experience With Telemedicine Consults to Assess Neonatal Encephalopathy in a Rural State.
Pediatr Neurol
November 2024
Associate Professor of Pediatrics, Tufts University School of Medicine, Boston, Massachusetts; Division of Pediatric Neurology, Department of Pediatrics, The Barbara Bush Children's Hospital at Maine Medical Center, Portland, Maine. Electronic address:
Background: Serial neonatal encephalopathy (NE) examinations are difficult to perform in rural community hospitals as on-site experts are not readily available. We implemented a synchronous, acute care model of teleconsultation-the Maine Neonatal Encephalopathy Teleconsultation program (Maine NET)-to provide remote, joint assessment of NE by pediatric neurology and neonatology at nine community hospitals and one tertiary care center. We performed a qualitative study to interview clinicians about their experience of this program.
View Article and Find Full Text PDFObtaining first-line induction in autoimmune hepatitis: Aren't we underestimating prednisolone?
J Hepatol
February 2025
Pediatric Gastroenterology and Hepatology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Navigating Dravet syndrome in Spain: A cross-sectional study of diagnosis, management, and care coordination.
Epilepsia Open
October 2024
Dravet Syndrome Foundation Spain, Madrid, Spain.
Objectives: Dravet syndrome (DS) is a rare form of refractory epilepsy that begins in the first year of life. Approximately 85% of patients have a mutation in the SCN1A gene, which encodes a voltage-gated sodium channel. The main objective of the present work was to assess the degree of knowledge of DS among Spanish primary care (PC) professionals, the communication flow between them and the pediatric neurologists (PNs), and the services available and resources offered to patients in Spain when searching for a diagnosis and adequate treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!